HemaCare Completes Sale of 400,000 Shares of Stock
- Share via
HemaCare Corp., a Sherman Oaks company that sells blood-related products and services, said it has completed a private placement of $2 million of its common stock.
The 400,000 shares were sold at $5 each, 23% less than the closing price of HemaCare common stock on April 30, the company said.
Proceeds from the stock sale will be used to fund HemaCare’s ongoing testing and development of an experimental therapy for acquired immune deficiency syndrome patients.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
